Schlafen 12 expression modulates prostate cancer cell differentiation

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Schlafen proteins are implicated in leukocyte and intestinal epithelial differentiation.
• Schlafen 12 (SLFN12) is investigated for its role in human prostate epithelial cells.

Purpose of the Study:

• To determine if SLFN12 overexpression modulates prostate-specific antigen (PSA) and dipeptidyl peptidase 4 (DPP4) expression.
• To explore the role of SLFN12 in prostate epithelial differentiation markers.

Main Methods:

• Adenoviral vectors were used to overexpress SLFN12 in LNCaP and PC-3 prostate cancer cell lines.
• Real-time RT-PCR and Western blotting assessed transcript and protein levels of SLFN12, PSA, and DPP4.
• Inhibitors of ERK and MLK pathways were used to investigate their involvement.

Main Results:

• SLFN12 overexpression significantly reduced PSA expression by 56.6% and increased DPP4 transcript levels by 4.8-fold.
• SLFN12 increased the mature E-cadherin protein ratio and promoted DPP4 expression even when MLK or ERK was inhibited.
• ERK inhibition did not alter SLFN12-induced changes in PSA, E-cadherin, or DPP4.

Conclusions:

• SLFN12 appears to regulate prostate epithelial cell differentiation, potentially independent of ERK or MLK signaling pathways.
• Understanding SLFN12's function could reveal therapeutic targets for prostate cancer.